Trial
NCT03607955
Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
Aravive, Inc.
Condition
Epithelial Ovarian Cancer
Intervention
AVB-S6-500
Why stopped
Trial may move forward as an NCI-sponsored trial and not an investigator initiated trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-29